Mutation of cancer driver MLL2 results in transcription stress and genome instability

  1. Jesper Q. Svejstrup1
  1. 1Mechanisms of Transcription Laboratory, Clare Hall Laboratories, The Francis Crick Institute, South Mimms EN6 3LD, United Kingdom;
  2. 2Bioinformatics and Biostatistics Group, The Francis Crick Institute, London WC2A 3LY, United Kingdom;
  3. 3Biotechnologisches Zentrum, Technische Universität Dresden, 01062 Dresden, Germany;
  4. 4Advanced Sequencing Facility, The Francis Crick Institute, London WC2A 3LY, United Kingdom
  1. Corresponding author: jesper.svejstrup{at}crick.ac.uk
  • 5 Present address: Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

Abstract

Genome instability is a recurring feature of tumorigenesis. Mutation in MLL2, encoding a histone methyltransferase, is a driver in numerous different cancer types, but the mechanism is unclear. Here, we present evidence that MLL2 mutation results in genome instability. Mouse cells in which MLL2 gene deletion can be induced display elevated levels of sister chromatid exchange, gross chromosomal aberrations, 53BP1 foci, and micronuclei. Human MLL2 knockout cells are characterized by genome instability as well. Interestingly, MLL2 interacts with RNA polymerase II (RNAPII) and RECQL5, and, although MLL2 mutated cells have normal overall H3K4me levels in genes, nucleosomes in the immediate vicinity of RNAPII are hypomethylated. Importantly, MLL2 mutated cells display signs of substantial transcription stress, and the most affected genes overlap with early replicating fragile sites, show elevated levels of γH2AX, and suffer frequent mutation. The requirement for MLL2 in the maintenance of genome stability in genes helps explain its widespread role in cancer and points to transcription stress as a strong driver in tumorigenesis.

Keywords

Footnotes

  • Received November 25, 2015.
  • Accepted January 15, 2016.

This article, published in Genes & Development, is available under a Creative Commons License (Attribution 4.0 International), as described at http://creativecommons.org/licenses/by/4.0/.

| Table of Contents
OPEN ACCESS ARTICLE

Life Science Alliance